Anna Rivkin's most recent trade in Foghorn Therapeutics Inc was a trade of 165,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc | Anna Rivkin | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 165,000 | 165,000 | - | - | Stock option (right to buy) | |
| Foghorn Therapeutics Inc | Anna Rivkin | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Anna Rivkin | Chief Business Officer | 03 Sep 2024 | 190,000 | 190,000 | - | - | Stock Options (Right to buy) |